Profile
Sector:
HealthcareIndustry:
Diagnostics & ResearchCountry:
United StatesIPO:
30 June 2017Website:
http://endrainc.comNext earnings report:
28 March 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 21 Nov 2024 00:57:29 GMTDividend
Analysts recommendations
Institutional Ownership
NDRA Latest News
ANN ARBOR, Mich.--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and nine months ended September 30, 2024 and provided a business update. Highlights from the third quarter and recent weeks include: Developed data analysis features for TAEUS platform by introducing new models rooted in artificial intelligence (AI), machine learning (ML) and deep learning (DL). As part of its conti.
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2024 Earnings Conference Call August 22, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Alexander Tokman - Acting CEO Ziad Rouag - Head of Regulatory and Clinical Affairs Michael Thornton - Chief Technology Officer Richard Jacroux - CFO Conference Call Participants Edward Woo - Ascendiant Capital Operator Good afternoon, and welcome to the ENDRA Life Sciences Second Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NALFD--ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that it has priced a public offering with gross proceeds to the Company expected to be approximately $8.0 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering is a best-efforts offering, with no minimum amount of securities required to be sold. The offering is.
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best will host a complimentary webinar titled “The Case for Engaging Defense Counsel Pre-Lawsuit,” on June 25, 2024, at 2:00 p.m. ET. In this webinar, sponsored by Three Griffins, Inc., a panel of insurance claims experts will examine the path from claim to lawsuit, and best practices on minimizing loss through appropriate legal consultation. Register now. Panelists include: Daniel Herbert, president/CEO, Three Griffins, Inc. Donald J. Richardson, shareholder,.
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2024 Earnings Call Transcript May 14, 2024 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and CEO Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Welcome to the ENDRA Life Sciences First Quarter 2024 Financial Results Conference call. All participants will be in a listen-only mode.
ENDRA Life Sciences Inc. (NDRA) Q4 2023 Earnings Call Transcript
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q3 2023 Results Conference Call November 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Third Quarter 2023 Financial Results Conference Call. All participants will be in a listen-only mode.
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman and Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director, Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
ENDRA Life Sciences Inc. (NASDAQ:NDRA ) Q1 2023 Earnings Conference Call May 15, 2023 4:30 PM ET Company Participants Yvonne Briggs - LHA Investor Relations Francois Michelon - Chairman & Chief Executive Officer Michael Thornton - Chief Technology Officer Irina Pestrikova - Senior Director of Finance Conference Call Participants Edward Woo - Ascendiant Capital Operator Good day, and welcome to the ENDRA Life Sciences Inc. First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
What type of business is ENDRA Life Sciences?
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
What sector is ENDRA Life Sciences in?
ENDRA Life Sciences is in the Healthcare sector
What industry is ENDRA Life Sciences in?
ENDRA Life Sciences is in the Diagnostics & Research industry
What country is ENDRA Life Sciences from?
ENDRA Life Sciences is headquartered in United States
When did ENDRA Life Sciences go public?
ENDRA Life Sciences initial public offering (IPO) was on 30 June 2017
What is ENDRA Life Sciences website?
https://endrainc.com
Is ENDRA Life Sciences in the S&P 500?
No, ENDRA Life Sciences is not included in the S&P 500 index
Is ENDRA Life Sciences in the NASDAQ 100?
No, ENDRA Life Sciences is not included in the NASDAQ 100 index
Is ENDRA Life Sciences in the Dow Jones?
No, ENDRA Life Sciences is not included in the Dow Jones index
When was ENDRA Life Sciences the previous earnings report?
No data
When does ENDRA Life Sciences earnings report?
The next expected earnings date for ENDRA Life Sciences is 28 March 2025